Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI), phase II trial Academic Article uri icon

Overview

MeSH Major

  • Hemorrhage
  • Myocardial Infarction
  • Thrombolytic Therapy

abstract

  • Increased morbidity due to hemorrhagic complications is associated with an invasive management strategy in patients with acute myocardial infarction. Our findings show the complex interaction of several factors in the occurrence of hemorrhagic events during thrombolytic therapy.

publication date

  • August 15, 1991

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 1906692

Additional Document Info

start page

  • 256

end page

  • 65

volume

  • 115

number

  • 4